Combination therapy may offer better outcomes for patients with retinoblastoma
Saturday, April 16, 2016 - 03:01
in Health & Medicine
Targeting survivin -- a protein that inhibits apoptosis or cell death -- enhances the effectiveness of chemotherapy in cells and mouse models of retinoblastoma (Rb), the most common malignant tumor of the eye in children, researchers report.